Failure of treatment of pneumonia associated with highly resistant pneumococci in a child

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 462-463

  Dowell, Scott F ^a,b,c   Smith, Tammy ^b,c   Leversedge, Kimberly ^b,c   Snitzer, Joseph ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c Pediatric Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; ERYTHROMYCIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; CASE REPORT; CHILD; CLINICAL FEATURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PHYSICAL EXAMINATION; PNEUMONIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0032777117     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/588389     Document Type: Article

References (8)

1. 1. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
2. 2. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J 1995;14:885-90.
3. 3. Feikin D, Cetron M, Schuchat A, Facklam R, Jorgenson J, Kolczak M. Mullistate population-based assessment of drug resistant S. pneumoniae mortality [abstract no 48]. Clin Infect Dis 1997;25:364.
4. 4. Daum RS, Nachman JP, Leiten CD, Tenover FC. Nosocomial epiglottitis associated with penicillin-and cephalosporin-resistant Streptococcus pneumoniae bacteremia. J Clin Microbiol 1994;32:246-8.
5. 5. Chesney PJ, Davis Y, English BK, Wang WC. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease. Pediatr Infect Dis J 1995;14:1013-4.
6. 6. Buckingham SC, Brown SP, San Joaquin VH. Breakthrough bacteremía and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J Pediatr 1998;132:174-6.
7. 7. Dowell SF, Butler JC, Giebink GS, et al. Otitis media - management and surveillance in an era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group (DRSPTWG). Pediatr Infect Dis J 1999;18:1-9.
8. 8. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-12.